Name
osaühing Silmake
Registry code
10162887
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.11.1996 (27)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
86221 - Provision of specialised medical treatment
43 115 €
10 180 €
24%
1 336 €
(estimate is approximate)
22 423 €
1
Submitted
No tax arrears
45%
40%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Galina Beloussova 14.10.1953 (71) | 100% - 40 000.00 EEK | Board member | Direct ownership |
| 2019 28.10.2020 | 2020 29.06.2021 | 2021 24.02.2022 | 2022 28.02.2023 | 2023 25.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 41 345 € | 35 485 € | 33 065 € | 37 370 € | 43 115 € |
| Net profit (loss) for the period | 3 094 € | 3 070 € | 4 731 € | 8 251 € | 10 180 € |
| Profit Margin | 7% | 9% | 14% | 22% | 24% |
| Current Assets | 7 060 € | 8 427 € | 12 664 € | 21 101 € | 25 449 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 7 060 € | 8 427 € | 12 664 € | 21 101 € | 25 449 € |
| Current Liabilities | 4 879 € | 3 176 € | 2 683 € | 2 869 € | 3 026 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 2 181 € | 5 251 € | 9 981 € | 18 232 € | 22 423 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 1 715.91 € | 1 817.64 € | 2 |
| 2023 Q4 | - | 1 669.05 € | 1 770.78 € | 2 |
| 2023 Q3 | - | 1 669.05 € | 1 770.78 € | 2 |
| 2023 Q2 | - | 1 669.05 € | 1 770.78 € | 2 |
| 2023 Q1 | - | 3 047.17 € | 1 637.56 € | 2 |
| 2022 Q4 | - | 1 453.41 € | 1 538.13 € | 2 |
| 2022 Q3 | - | 1 453.41 € | 1 538.13 € | 2 |
| 2022 Q2 | - | 1 453.41 € | 1 538.13 € | 2 |
| 2022 Q1 | - | 1 449.75 € | 1 520.46 € | 2 |
| 2021 Q4 | - | 1 449.75 € | 1 520.46 € | 2 |
| 2021 Q3 | - | 1 450.75 € | 1 520.46 € | 2 |
| 2021 Q2 | - | 1 449.75 € | 1 520.46 € | 2 |
| 2021 Q1 | - | 1 435.23 € | 1 505.94 € | 2 |
| 2020 Q4 | - | 2 081.84 € | 2 165.77 € | 2 |
| 2020 Q3 | - | 2 254.8 € | 2 342.85 € | 3 |
| 2020 Q2 | - | 1 063.58 € | 1 111.61 € | 3 |
| 2020 Q1 | - | 2 135.4 € | 2 221.83 € | 3 |
